Clearline Capital LP Sells 339,454 Shares of The Cooper Companies, Inc. $COO

Clearline Capital LP reduced its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 89.3% during the fourth quarter, Holdings Channel reports. The fund owned 40,636 shares of the medical device company’s stock after selling 339,454 shares during the period. Clearline Capital LP’s holdings in Cooper Companies were worth $3,331,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Concentric Capital Strategies LP bought a new position in Cooper Companies during the fourth quarter valued at approximately $11,119,000. Aureus Asset Management LLC bought a new position in Cooper Companies during the fourth quarter valued at approximately $237,000. Balyasny Asset Management L.P. grew its position in Cooper Companies by 348.3% during the fourth quarter. Balyasny Asset Management L.P. now owns 495,895 shares of the medical device company’s stock valued at $40,644,000 after acquiring an additional 385,286 shares during the last quarter. Armistice Capital LLC grew its position in Cooper Companies by 212.7% during the fourth quarter. Armistice Capital LLC now owns 17,888 shares of the medical device company’s stock valued at $1,466,000 after acquiring an additional 12,167 shares during the last quarter. Finally, American Trust bought a new position in Cooper Companies during the fourth quarter valued at approximately $216,000. 24.39% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

COO has been the topic of a number of recent research reports. Needham & Company LLC reduced their price target on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a research report on Friday, June 5th. Stifel Nicolaus dropped their price objective on Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research note on Friday, June 5th. JPMorgan Chase & Co. dropped their price objective on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research note on Friday, June 5th. Weiss Ratings lowered Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research note on Monday, June 8th. Finally, Wells Fargo & Company reissued a “sell” rating and set a $66.00 price objective (down from $82.00) on shares of Cooper Companies in a research note on Friday, June 5th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $81.31.

Cooper Companies Stock Performance

NASDAQ:COO opened at $65.05 on Thursday. The firm has a market cap of $12.69 billion, a PE ratio of 55.13, a price-to-earnings-growth ratio of 1.76 and a beta of 0.87. The Cooper Companies, Inc. has a fifty-two week low of $58.89 and a fifty-two week high of $89.83. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The business has a 50 day moving average price of $64.58 and a 200-day moving average price of $74.10.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The firm had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities research analysts predict that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.